Structure Therapeutics CSO Lin Xichen reports disposal of common shares worth $207,378.61

• Structure Therapeutics Chief Scientific Officer Lin Xichen exercised share options for 11,817 ordinary shares at USD 0.34 on Aug. 18, 2026.
• Those shares were converted into 3,939 American Depositary Shares.
• Lin sold 3,939 American Depositary Shares on Aug. 18 at weighted-average prices of USD 53.13, USD 54.2, USD 55.05.
• Directly held ordinary shares fell to 228,960; share options outstanding declined to 142,898.
• Lin ended the day with no American Depositary Shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Structure Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001962926-26-000008), on August 19, 2026, and is solely responsible for the information contained therein.